All News

Long-term follow-up of the JULIET trial showed patients with relapsed or refractory DLBCL continued to experience durable responses 19 months after treatment.

Feelings of sadness and depression are common among those affected by cancer, but there may be another reason behind those feelings.

Especially during holiday seasons, we remember loved ones who are not with us. Even long after they have passed, we can cherish old memories and even make new ones with the help of social media. Recently I learned something sweet about my brother John, who died of Hodgkin's lymphoma decades ago, from a high school friend I never knew about.

Treatment with Xarelto (rivaroxaban) may reduce the risk for developing blood clots during active treatment with a systemic therapy like chemotherapy, according to results from the CASSINI trial.

The FDA has granted a priority review designation to a supplemental biologics license application (sBLA) for Tecentriq (atezolizumab) for use in combination with carboplatin and etoposide for the frontline treatment of patients with extensive-stage small cell lung cancer (ES-SCLC).

A new program offers counseling, patient education and vetted referrals to patients and their families.

Maintenance treatment with Lynparza (olaparib) after chemotherapy has been found to significantly extend progression-free survival in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation, according to a recent phase 3 study.

Emotions are not an either/or proposition when it comes to metastatic cancer.

Administering Imbruvica with CAR-T cell therapy improved outcomes in patients with chronic lymphocytic leukemia, according to recent research.

The challenge of caring for yourself and your child while dealing with cancer is daunting.

An oncologist and three advocates were honored for their work on behalf of people with chronic lymphocytic leukemia.

A retrospective study found that clinical trials may have fewer reported side effects than the real world.

A new television show, as well as a recent CURE campaign, gave insight to life with cancer.

Here are the top 5 CURE stories for November 2018.

A little awareness can help make us immune to cancer scams.

As people who have "been there, done that," our very presence provides a new arrival on the cancer rollercoaster a sense of stability and certainty.

At the MPN Heroes Event, Olympic skater Scott Hamilton discusses importance of advocacy and research.

I would tune out or give an unsympathetic nod when I would hear people talk about anxiety because I didn't understand what it really was or how paralyzing it could be. That was until I got cancer.

Recent research found that some patients with lung cancer have misconceptions about their prognosis, as well as how palliative care can help.

Learn to incorporate healthy foods into your diet as part of a wellness warrior lifestyle.

Take a look at the FDA’s decisions for the treatment of SLL that happened this year.

While the treatment landscape continues to grow in bladder cancer, researchers should continue to follow the evidence, but accrual of patients in clinical trials is also key, according to Petros Grivas, M.D., Ph.D.

Wouldn't it be nice to forget a cancer diagnosis?

The Food and Drug Administration (FDA) approved Xospata (gilteritinib) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) who have a FLT3 mutation that is detected by an FDA-approved test, according to the agency.

The Food and Drug Administration (FDA) approved Truxima (rituximab-abbs) – the first biosimilar of Rituxan (rituximab) – to treat adults with CD20-positive, B-cell non-Hodgkin lymphoma (NHL).

November is Lung Cancer Awareness Month, and our Lung Cancer Special Issue is offering new insights into the treatment of the disease.

Forgiveness is more than just words, it's feelings. Learning how to forgive others can help us in our cancer journey as well.

These are my thoughts on religion and cancer, but they may not be yours. Either way, I ask you to keep an open mind.